These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36276282)

  • 1. Resveratrol Enhances the Radiosensitivity by Inducing DNA Damage and Antitumor Immunity in a Glioblastoma Rat Model under 3 T MRI Monitoring.
    Qian L; Mao L; Mo W; Wang R; Zhang Y
    J Oncol; 2022; 2022():9672773. PubMed ID: 36276282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
    Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
    J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-elemene enhances both radiosensitivity and chemosensitivity of glioblastoma cells through the inhibition of the ATM signaling pathway.
    Liu S; Zhou L; Zhao Y; Yuan Y
    Oncol Rep; 2015 Aug; 34(2):943-51. PubMed ID: 26062577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 Inhibitor Regulates the miR-33a-5p/PTEN Signaling Pathway and Can Be Targeted to Sensitize Glioblastomas to Radiation.
    Xia W; Zhu J; Tang Y; Wang X; Wei X; Zheng X; Hou M; Li S
    Front Oncol; 2020; 10():821. PubMed ID: 32537433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1.
    Tan Y; Wei X; Zhang W; Wang X; Wang K; Du B; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1833-1841. PubMed ID: 28184930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.
    Lin XM; Shi XX; Xiong L; Nie JH; Ye HS; Du JZ; Liu J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
    Zhou X; Lv L; Tan Y; Zhang Z; Wei S; Xiao S
    Brain Res; 2021 Sep; 1766():147515. PubMed ID: 33984327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells.
    Filippi-Chiela EC; Thomé MP; Bueno e Silva MM; Pelegrini AL; Ledur PF; Garicochea B; Zamin LL; Lenz G
    BMC Cancer; 2013 Mar; 13():147. PubMed ID: 23522185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells.
    Filippi-Chiela EC; Villodre ES; Zamin LL; Lenz G
    PLoS One; 2011; 6(6):e20849. PubMed ID: 21695150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown
    Timme CR; Rath BH; O'Neill JW; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 Jun; 17(6):1207-1216. PubMed ID: 29549168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways.
    Rashid A; Liu C; Sanli T; Tsiani E; Singh G; Bristow RG; Dayes I; Lukka H; Wright J; Tsakiridis T
    Radiat Oncol; 2011 Oct; 6():144. PubMed ID: 22029423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol exerts antitumor effects by downregulating CD8
    Zhang Q; Huang H; Zheng F; Liu H; Qiu F; Chen Y; Liang CL; Dai Z
    Oncoimmunology; 2020 Oct; 9(1):1829346. PubMed ID: 33150044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway.
    Yuan Y; Xue X; Guo RB; Sun XL; Hu G
    CNS Neurosci Ther; 2012 Jul; 18(7):536-46. PubMed ID: 22530672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma.
    Xie S; Hong Z; Li Y; Wang J; Wang J; Li S; Liu Y
    Mol Neurobiol; 2022 Aug; 59(8):4703-4717. PubMed ID: 35594003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Reactive Oxygen Species and Distinct Oxidative Damage in Resveratrol-suppressed Glioblastoma Cells.
    Jia B; Zheng X; Wu ML; Tian XT; Song X; Liu YN; Li PN; Liu J
    J Cancer; 2021; 12(1):141-149. PubMed ID: 33391410
    [No Abstract]   [Full Text] [Related]  

  • 17. Exosomal B7-H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth.
    Tian Y; Liu C; Li Z; Ai M; Wang B; Du K; Liu W; Wang H; Yu P; Chen C; Lin J; Xu A; Li R; Zhang W; Yuan Y
    Redox Biol; 2022 Oct; 56():102454. PubMed ID: 36044789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review.
    Arabzadeh A; Mortezazadeh T; Aryafar T; Gharepapagh E; Majdaeen M; Farhood B
    Cancer Cell Int; 2021 Jul; 21(1):391. PubMed ID: 34289841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas.
    Xue S; Xiao-Hong S; Lin S; Jie B; Li-Li W; Jia-Yao G; Shun S; Pei-Nan L; Mo-Li W; Qian W; Xiao-Yan C; Qing-You K; Peng Z; Hong L; Jia L
    Oncotarget; 2016 Nov; 7(46):75790-75799. PubMed ID: 27716625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition.
    Tsai CY; Ko HJ; Chiou SJ; Lai YL; Hou CC; Javaria T; Huang ZY; Cheng TS; Hsu TI; Chuang JY; Kwan AL; Chuang TH; Huang CF; Loh JK; Hong YR
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.